Clindamycin: clinical and laboratory evaluation of parenteral therapy.
D000196:Actinomycosis / Q000188:drug therapy; D000284:Administration, Oral; D000410:Alanine Transaminase / Q000097:blood; D000818:Animals; D001219:Aspartate Aminotransferases / Q000097:blood; D001424:Bacterial Infections / Q000188:drug therapy*; D002981:Clindamycin / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use / Q000652:urine; D000882:Haplorhini; D006801:Humans; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D008034:Lincomycin / Q000008:administration & dosage*; D008826:Microbial Sensitivity Tests; D010019:Osteomyelitis / Q000188:drug therapy; D010612:Pharyngitis / Q000188:drug therapy; D011008:Pneumococcal Infections / Q000188:drug therapy; D011014:Pneumonia / Q000188:drug therapy; D013203:Staphylococcal Infections / Q000188:drug therapy; D013290:Streptococcal Infections / Q000188:drug therapy
D002981:Clindamycin; D008034:Lincomycin; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase